WallStSmart

Beauty Health Co (SKIN)vsTarget Corporation (TGT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Target Corporation generates 37034% more annual revenue ($107.70B vs $290.05M). TGT leads profitability with a 4.1% profit margin vs -9.8%. SKIN appears more attractively valued with a PEG of 0.93. TGT earns a higher WallStSmart Score of 66/100 (B-).

SKIN

Hold

45

out of 100

Grade: D+

Growth: 2.7Profit: 2.5Value: 6.0Quality: 4.5
Piotroski: 6/9Altman Z: -0.38

TGT

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 6.0Value: 6.0Quality: 4.5
Piotroski: 3/9Altman Z: 2.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SKIN.

TGTUndervalued (+5.3%)

Margin of Safety

+5.3%

Fair Value

$120.98

Current Price

$155.83

$34.85 discount

UndervaluedFair: $120.98Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SKIN2 strengths · Avg: 8.0/10
PEG RatioValuation
0.938/10

Growing faster than its price suggests

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

TGT5 strengths · Avg: 8.8/10
EPS GrowthGrowth
100.5%10/10

Earnings expanding 100.5% YoY

Market CapQuality
$70.79B9/10

Large-cap with strong market position

Return on EquityProfitability
24.6%9/10

Every $100 of equity generates 25 in profit

P/E RatioValuation
16.2x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$2.43B8/10

Generating 2.4B in free cash flow

Areas to Watch

SKIN4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$88.50M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
5.0%3/10

Operating margin of 5.0%

Return on EquityProfitability
-10.9%2/10

ROE of -10.9% — below average capital efficiency

TGT4 concerns · Avg: 3.3/10
PEG RatioValuation
1.944/10

Expensive relative to growth rate

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Debt/EquityHealth
1.053/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : SKIN

The strongest argument for SKIN centers on PEG Ratio, Price/Book. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : TGT

The strongest argument for TGT centers on EPS Growth, Market Cap, Return on Equity.

Bear Case : SKIN

The primary concerns for SKIN are EPS Growth, Market Cap, Operating Margin. Debt-to-equity of 6.60 is elevated, increasing financial risk.

Bear Case : TGT

The primary concerns for TGT are PEG Ratio, Profit Margin, Debt/Equity. Thin 4.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

SKIN profiles as a turnaround stock while TGT is a value play — different risk/reward profiles.

SKIN carries more volatility with a beta of 0.99 — expect wider price swings.

TGT is growing revenue faster at 5.3% — sustainability is the question.

TGT generates stronger free cash flow (2.4B), providing more financial flexibility.

Bottom Line

TGT scores higher overall (66/100 vs 45/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Beauty Health Co

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.

Target Corporation

CONSUMER DEFENSIVE · DISCOUNT STORES · USA

Target Corporation is an American retail corporation. Their retail formats include the discount store Target, the hypermarket SuperTarget, and small-format stores previously named CityTarget and TargetExpress before being consolidated under the Target branding.

Want to dig deeper into these stocks?